2bind GmbH

Business Strategies

The 2bind GmbH is a service provider in the field of biophysical analyses: From Stability to Affinity. Our customers and collaborators mainly work in the fields of drug development, aptamer generation, and antibody discovery. Our mission is to support and help our partners with our innovative analyses to drive their science.

Core Technologies

2bind is a contract research organization (CRO) in the area of biophysical analytics to study molecular interactions. We offer customized analytical services with focus on early drug development (hit identification, hit validation and hit characterization) and antibody development.

13 core technologies  allow our experts for studying molecular interactions in terms of classical binding parameters such as affinity, kinetics, thermodynamics and stoichiometry.

We offer a broad portfolio of biophysical assays starting at High Throughput Screening, Binding analyses in bioliquids (such as sera) up to competition assays or kinetic studies on cell surfaces.

2bind has strong ties to technology developers such as NanoTemper, Dynamic Biosensors, Creoptix or Wyatt thereby acting as beta tester for novel technologies, which underlines 2bind´s deep understanding of biophysical methods.

Our Biotech and Pharma customers benefit from a strong expertise in biophysical methods, from customized milestone-based projects with clear timelines and reliable cost structures.

Since 2011 2bind successfully finished over 1500 projects for more than 500 customers, which are 8 of the top 10 worldwide pharmaceutical companies, Biotechs, SMEs and universities.

Be smart – work with the experts in biophysics!